IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

STELLIX PHARMACEUTICALS LLP

LLPIN : ACF-5156|ROC: RoC-MumbaiActive
Last Updated On : 14-02-2024
LLPINACF-5156
LLP NameSTELLIX PHARMACEUTICALS LLP
Number of Partners5
Number of Designated Partners5
ROC CodeRoC-Mumbai
Date of Incorporation13-02-2024
Registered Address17, Basement-Floor, Sukh Sagar, Nyaymurti Sitaram Patkar Marg, Chowpaty, Grant Road, Mumbai Grant Road Mumbai Mumbai Maharashtra 400007
Email IDStellixpharmaceuticals@gmail.com
Total Obligation of Contribution50,000
Main division of business activity to be carried out in India46
LLP StatusActive

Directors / Signatory Details

STELLIX PHARMACEUTICALS LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Mumbai, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 13-02-2024 and last updated on 14-02-2024. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, STELLIX PHARMACEUTICALS LLP has a total contribution of INR 50,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is 17, Basement-Floor, Sukh Sagar, Nyaymurti Sitaram Patkar Marg, Chowpaty, Grant Road, Mumbai Grant Road Mumbai Mumbai Maharashtra 400007. Correspondence or inquiries may be sent to the official email address, Stellixpharmaceuticals@gmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

The information above is compiled from the publicly available data on the MCA website. To confirm any details or get the latest status, please consult the official Ministry of Corporate Affairs (MCA) portal or authorized representatives.